LIMITATIONS OF PRESENTLY AVAILABLE INVITRO RELEASE DATA FOR THE PREDICTION OF INVIVO PERFORMANCE

被引：11

作者：

KOTTKE, MK

RHODES, CT

机构：

[1] University of Rhode Island, Department of Pharmaceutics, Kingston, RI

来源：

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY | 1991年 / 17卷 / 09期

关键词：

D O I：

10.3109/03639049109043851

中图分类号：

R914 [药物化学];

学科分类号：

100701 [药物化学];

摘要：

[No abstract available]

引用

页码：1157 / 1176

页数：20

共 21 条

[1]

ABDOU HM, 1989, DISSOLUTION BIOAVAIL, P491

[2]

BANAKAR UV, 1983, PHARM TECH, V7, P115

[3]

BANAKAR UV, 1983, PHARM TECH, V7, P117

[4]

BANAKAR UV, 1983, PHARM TECH, V7, P112

[5]

Banakar UV, 1983, PHARM TECHNOL, V7, P107

[6]

FURTHER CONSIDERATIONS IN CORRELATING INVITRO - INVIVO DATA EMPLOYING MEAN-TIME CONCEPT BASED ON STATISTICAL MOMENTS [J].

BLOCK, LH ;

BANAKAR, UV .

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1988, 14 (15-17) :2143-2150

[7]

PHARMACOKINETIC INVESTIGATION OF THE ABSORPTION OF OXPRENOLOL FROM OROS DELIVERY SYSTEMS IN HEALTHY-VOLUNTEERS - COMPARISON OF INVIVO AND INVITRO DRUG RELEASE [J].

BRADBROOK, ID ;

JOHN, VA ;

MORRISON, PJ ;

ROGERS, HJ ;

SPECTOR, RG .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 :S163-S169

[8]

IBUPROFEN TABLETS DISSOLUTION VERSUS BIOAVAILABILITY [J].

DASH, BH ;

BLANK, RG ;

SCHACHTEL, BP ;

SMITH, AJ .

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1988, 14 (11) :1629-1645

[9]

DROMERO AJ, 1988, DRUG DEV IND PHARM, V14, P1499

[10]

INVITRO INVIVO CORRELATION AND DISSOLUTION STUDIES WITH ORAL THEOPHYLLINE DOSAGE FORMS [J].

ELYAZIGI, A ;

SAWCHUK, RJ .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (02) :161-164

← 1 2 3 →